Company（https://www.nanoalvand.com/en/company.html）
Products（https://www.nanoalvand.com/en/products.html）
Business Development（https://www.nanoalvand.com/en/business-development.html）
Careers（https://www.nanoalvand.com/en/careers.html）
Blog（https://www.nanoalvand.com/en/blog.html）
Contact（https://www.nanoalvand.com/en/contact.html）
Our Commitment Is:
Wide Range High-Quality Reasonably Priced Medications
Field of Activities and Global Responsibilities
Our Diverse Portfolio: Beyond Oncology to Holistic Treatment Approaches
While our primary focus remains on pioneering cancer therapies, NanoAlvand also excels in developing advanced treatments for multiple sclerosis, rheumatoid arthritis, immunosuppressants medications, and other innovative medicines.
+12
Exporting Destinations
3
Export Continents
+20
Registration Projects
+126
Total FDF
Partnering
Finding the ideal partner and developing a preliminary business case based on the country’s needs are the first steps in our partnership process. The process will proceed from initial negotiations to the signing and finalization of agreements, incorporating a thorough due diligence phase before making a strategic entry into the target market. Serving our clients' needs by providing access to wide range of high-quality, reasonably priced medications is the mission of our business development team.
Business Models
Supply and Distribution
Product Development
Joint-Venture
Technology Transfer
Contract Manufacturing
In-licensing